Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Assets Average (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Assets Average over the past 15 years, most recently at $238.5 million for Q2 2025.

  • Quarterly results put Assets Average at $238.5 million for Q2 2025, down 4.63% from a year ago — trailing twelve months through May 2025 was $238.5 million (down 4.63% YoY), and the annual figure for FY2025 was $246.7 million, down 2.8%.
  • Assets Average for Q2 2025 was $238.5 million at Lifecore Biomedical, Inc. \De\, down from $246.5 million in the prior quarter.
  • Over the last five years, Assets Average for LFCR hit a ceiling of $504.4 million in Q2 2021 and a floor of $238.5 million in Q2 2025.
  • Median Assets Average over the past 5 years was $253.7 million (2023), compared with a mean of $311.5 million.
  • Biggest five-year swings in Assets Average: rose 19.58% in 2021 and later tumbled 42.84% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Assets Average stood at $433.0 million in 2021, then tumbled by 37.38% to $271.2 million in 2022, then decreased by 9.39% to $245.7 million in 2023, then increased by 2.19% to $251.1 million in 2024, then dropped by 5.01% to $238.5 million in 2025.
  • The last three reported values for Assets Average were $238.5 million (Q2 2025), $246.5 million (Q1 2025), and $251.1 million (Q4 2024) per Business Quant data.